Wallerian degeneration of distal axons after nerve injury is significantly delayed in the Wld s mutant mouse. The Wld s protein is a fusion of nicotinamide mononucleotide adenyltransferase-1 (Nmnat1), an essential enzyme in the biosynthesis pathway of nicotinamide adenine dinucleotide (NAD), with the N-terminal 70 amino acids of the Ube4b ubiquitination assembly factor. The mechanism of Wld s action is still enigmatic, although recent efforts suggest that it is indirect and requires sequences flanking or linking the two fused open reading frames. Three papers in this issue of Neuron now show that Wld s action is conserved in Drosophila and that a critical role of Wld s may be the suppression of axonal self-destruct signals that induce Draper-mediated clearance of damaged axons by glial cells.
For the Snark's a peculiar creature, that won't Be caught in a commonplace way. Do all that you know, and try all that you don't: Not a chance must be wasted to-day! The above lines, penned by Lewis Carroll in his epic poem The Hunting of the Snark, describe a quest that has many parallels with recent efforts to understand the mode of axonal protection of the Wallerian degeneration slow (Wld s ) mutation. The Wld s mutant was described by Hugh Perry and colleagues 16 years ago as a mouse with the remarkable phenotype of extremely delayed degeneration of distal nerve projections after injury (Perry et al., 1990) . Although work in invertebrates had previously demonstrated survival and nondegeneration of severed axons for many weeks (Bittner, 1991) , this was not thought to occur in mammals. The Wld s mouse was striking, as the mutant phenotype suggested that axon degeneration is an active process intrinsic to the axon itself and not necessarily connected to classical cell death mechanisms in the cell body. An arduous process of positional cloning led to identification of the Wld s gene product as an in-frame fusion protein combining the N-terminal 70 amino acids of a ubiquitination assembly factor (Ube4b/Uf2a) with the entire coding sequence of nicotinamide mononucleotide adenyltransferase-1 (Nmnat-1), an essential enzyme in the biosynthesis pathway of nicotinamide adenine dinucleotide (NAD) ( Figure 1A ). Gene transfer of the Wld s protein slowed Wallerian degeneration in injury models in both mouse and rat, as well as axonal degeneration after toxic challenge, and in a number of neurodegenerative disease models (Coleman, 2005 , and references cited therein). These results indicated that a range of hitherto unlinked diseases and lesion paradigms share a fundamental mechanism of axonopathy, thus sparking keen interest in the mode of action of the Wld s protein. Indeed, if severed distal axons can survive and maintain their structure, re-establishing neuronal connectivity by fusion of cut ends without the need to slowly regrow axons may become a feasible goal, as has been demonstrated in Aplysia neurons (Bedi and Glanzman, 2001) . What Is the Active Domain in Wld s ? The nature of the Wld s gene product suggested two initial hypotheses for mode of action: on the one hand a putative dominant-negative effect of the ubiquitination factor fragment, and on the other hand activity of Nmnat1 via NAD biosynthesis. Many favored the former possibility, since proteosome inhibitors were shown to inhibit axonal self-destruction (Zhai et al., 2003) . Although ubiquitination factors are known to occur in axons, studies localizing the Wld s protein to the nucleus shed doubt on this possibility (Fang et al., 2005 , and references cited therein). Two recent papers suggested that Wld s activity can be restored in sensory neurons in vitro with NAD or Nmnat1 alone (Araki et al., 2004; Wang et al., 2005) , although they differ in their interpretation of the site of action. Araki et al. (2004) reported that Nmnat1 activates the NAD-dependent deacetylase Sirt1 in the nuclei of dorsal root ganglia (DRG) neurons cultured in vitro, suggesting that the axonal phenotype is an indirect consequence of Nmnat1 activities in the nucleus. Wang et al. (2005) used cultures of the same neuronal type to argue that a Sirt1-independent local mechanism in the axon is responsible for NAD-mediated protection. However, an in vivo study has now shown that Nmnat1 overexpression in transgenic mice is not sufficient to provide Wld s -like protection . Although Nmnat1 overexpression from a lentivirus vector afforded some axon protection, it was much less robust than Wld s . Moreover, a study in this issue of Neuron on the effects of transgenic Wld s in Drosophila (see below) shows that DNmnat also mimics Wld s effects at lower efficacy . The differences in Nmnat1 efficacy in the three mammalian studies might be explained by the very different time frames studied. The cultures of Araki et al. (2004) exhibited minimal degeneration in the first 12 hr after transection, whereas those of Wang et al. (2005) essentially completed degeneration within 12 hr. In contrast, the in vivo study of Conforti et al. (2006) looked at time points of 3-14 days after transection. Since neither the Ube4b or Nmnat1 domains of Wld s can fully recapitulate Wld s functionality in vivo , attention must now turn to regions outside these open reading frames, specifically the unique 18 amino acid linker region or 3 0 or 5 0 untranslated sequences ( Figure 1A) . Intriguingly, Laser et al. (2006) Wang et al. (2005) , who observed short-term protection of injured axons upon direct application of high concentrations of NAD concomitantly or even shortly after axon lesion. Other groups did not observe this acute effect of NAD , perhaps suggesting that it is effective only under certain conditions of stress or lesion. Buckmaster et al. (1995) showed that neuronal depolarization leading to elevated intracellular Ca 2+ delays Wallerian degeneration of the axon, and it is known that NAD or the phosphorylated form NADP can trigger calcium release from internal stores after conversion to cyclic ADP-ribose (cADPR) or NAADP, respectively (Berger et al., 2004) . The fall in NAD levels in lesioned wild-type axons reported by Wang et al. (2005) might reflect conversion to cADPR. Note however that excessive rise in calcium levels may contribute to axonal degeneration via calcium-activated proteases (Coleman, 2005) . Moreover, NAD supplementation was reported to preserve mitochondrial transmembrane potential and cellular respiration during oxidative stress (Du et al., 2003) . It is therefore conceivable that localized concentrations of NAD in axons can buffer mitochondria and prevent loss of mitochondrial function at a lesion site. Indeed, recent observations suggest that Wallerian degeneration progresses as a wave from the injury site, sequentially affecting adjacent regions of the axon (Beirowski et al., 2005) , thus a localized mechanism of NAD increase at the injury site in the axon might be an effective first line of defense. Although Nmnat1 and Wld s are predominantly nuclear proteins, this does not rule out the possibility that Wld s -encoding transcripts may occur in axons. Transient and regulated expression of ''nuclear'' proteins in axons may occur by local translation upon injury (Hanz et al., 2003) . If the Wld s transcript contains axon-targeting sequences, translation upon injury might upregulate Nmnat1 locally at the lesion site, a situation perhaps mimicked by the experiments of Wang et al. (2005) . Such transcripts may be found at low levels and/or in extremely localized distributions in neuronal processes, thus assessment of this possibility will require experiments in systems that allow clear separation of axons from cell bodies (e.g., MacInnis and Campenot, 2005; Taylor et al., 2005; Zheng et al., 2001) .
In contrast to the above, the nuclear site hypothesis for Wld s actions is based on the observations that immunohistochemistry definitively localizes the Wld s protein to nuclei (Fang et al., 2005 , and references cited therein) and that Wld s affects nuclear proteins such as SIRT1 and VCP/p97 (Laser et al., 2006; Michishita et al., 2005 ). Nuclear Wld s might indirectly prime axons for greater resistance to degeneration by inducing changes in neuronal gene expression or differential acetylation of axoplasmic proteins shipped out from the cell body. An initial microarray study has recently shown limited changes in gene expression in Wld s mouse cerebellum and further revealed that expression of two of the Wld s -regulated genes can be selectively modulated by Nmnat1 or truncated Ube4b (Gillingwater et al., 2006) . Pinpointing the critical aspects of the altered state of Wld s axons will most likely require a combination of transcriptome and proteome analyses, and the application of proteome-wide methods for analyses of differential protein modifications (e.g., Dormeyer et al., 2005) (Awasaki et al., 2006; Hoopfer et al., 2006; MacDonald et al., 2006) . These groups examined the question of how excess or transected axons are cleared in the fly. Awasaki et al. (2006) showed that Draper, a scavenger receptor expressed in glia, and ced6, an intracellular transducer/adaptor that may interact with Draper, both function in glial engulfment of axons destined for pruning during development of Drosophila mushroom body neurons. MacDonald et al. (2006) (Hoopfer et al., 2006) . This suggests that early stages of developmental and postinjury degeneration of neuronal processes are mechanistically distinct, as previously implied from work on remodeling of the neuromuscular junction (Gillingwater and Ribchester, 2003) . Taken together, these findings imply that the axonal degeneration mechanisms targeted by Wld s are evolutionarily ancient and fundamental, and they validate fly genetics as a powerful approach to dissecting Wld s modes of action. Draper-mediated clearance of damaged axons by activated glia is extremely rapid and specific. Draper is upregulated in adjacent glia rapidly after axonal lesion, followed by expansion of glial membranes to engulf axonal fragments. The specificity of this process suggests that it is mediated by upregulation of ligands for Draper on the surfaces of axons marked for degeneration (Awasaki et al., 2006; MacDonald et al., 2006) . In developing Drosophila mushroom bodies, an ecdysone-mediated signal that leads to disruption of axonal microtubules may lead to surface expression of such putative Draper ligands (Awasaki et al., 2006) , while in transected ORN the initiating processes are unknown. Nonetheless, these studies suggest that one of the modes of action of Wld s in mammals may be by preventing or changing surface expression of such ''eat me'' signals on transected axons ( Figure 1B) . Mammalian homologs are known for both Draper and ced6 (Nagase et al., 2001; Su et al., 2002) , and it will be intriguing to find out whether mouse mutants for these genes have a Wld s -like phenotype. Efforts to identify Draper ligands in Drosophila are likely already underway, and once such ligands are identified the effects of Wld s on their expression, localization, and surface presentation in mammalian axons will be important issues to study. If such ligands provide a direct molecular readout of the Wld s phenotype, that will facilitate efforts to dissect the targeting or modulating elements that likely synergize with the Nmnat1 moiety in Wld s . Thus, the hunting of the SIRT should soon intersect with the luring of the Draper, and those engaged in this quest in the Wld s would do well to remember the cautionary closing lines of Lewis Carroll:
In the midst of the word he was trying to say, In the midst of his laughter and glee, He had softly and suddenly vanished awayFor the Snark was a Boojum, you see..
